PDPN and glioblastoma: As identified in TCGA gene expression analysis (Figure 1B), PDPN protein expression was prognostic for GBM patients’ overall survival (OS) in our cohort presented here; median OS for PDPN+ and PDPN− groups were 53.4 and 148.1 weeks, respectively (p<0.0001; Figure 1D).